Submitted by Anonymous (not verified) on 9 April 2026 - 16:05
Human medicines European public assessment report (EPAR): Iclusig, ponatinib, Date of authorisation: 01/07/2013, Revision: 28, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Iclusig, ponatinib, Date of authorisation: 01/07/2013, Revision: 28, Status: Authorised